Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lifecare ASA Capital/Financing Update 2021

Nov 9, 2021

3654_rns_2021-11-09_6236a6c0-2853-4e01-b03a-3fce6b2a40f6.html

Capital/Financing Update

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

Lifecare – Share capital increase registered

Lifecare – Share capital increase registered

Bergen 9 November 2021

Reference is made to the announcement published on 5 October 2021 by Lifecare AS (the “Company”) regarding the issue of 15,467,834 new shares upon completion of a private placement of shares.

The share capital increase pertaining to the issuance of new shares under the private placement has now been registered with the Norwegian Register of Business Enterprises. The Company's new registered share capital is NOK 39,193,658.8 divided into 97,984,147 shares, each with a par value of NOK 0.4.

This is Lifecare

Lifecare is a Bergen-based technology company developing a miniaturized implantable long-term sensor for correct and continuous monitoring of blood sugar in people with diabetes. The Company's patented technology also has the potential for use in various biomarkers. Lifecare AS is listed on Euronext Growth (LIFE).

For further information, please contact:

Joacim Holter, CEO, Lifecare AS, [email protected], +47 40 05 90 40

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.This stock exchange announcement was published by Kine Hereid, Investor Relations at Lifecare AS, on 09.11.2021 at 09.00 CET.